It is highly significant given that P16 positive tumors typically have a good prognosis regardless of stage or high-risk pathologic features, this prognostic mRNA signature classifier for P16 negative-related HNSCC may help clinicians to pinpoint those HNSCC patients at high risk of unfavorable OS.
← all excerpts
Identification of a Novel Epithelial-Mesenchymal Transition Gene Signature Predicting Survival in Patients With HNSCC.
1
—
—